|
IQGAP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13340000110307E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.58099999758576E-08 |
| Normal-vs-Stage2 |
9.99770000120748E-08 |
| Normal-vs-Stage3 |
8.12529998839295E-09 |
| Normal-vs-Stage4 |
2.21579999903909E-08 |
| Stage1-vs-Stage2 |
5.542000E-01 |
| Stage1-vs-Stage3 |
5.905200E-01 |
| Stage1-vs-Stage4 |
4.543600E-01 |
| Stage2-vs-Stage3 |
3.137000E-01 |
| Stage2-vs-Stage4 |
2.622600E-01 |
| Stage3-vs-Stage4 |
6.504200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65489999481849E-08 |
| Normal-vs-AfricanAmerican |
1.83610000537016E-08 |
| Normal-vs-Asian |
1.045570E-02 |
| Caucasian-vs-AfricanAmerican |
8.897600E-01 |
| Caucasian-vs-Asian |
4.549800E-01 |
| AfricanAmerican-vs-Asian |
4.933800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.58879999659456E-08 |
| Normal-vs-Female |
8.71520000611525E-09 |
| Male-vs-Female |
3.243400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.25209997504339E-09 |
| Normal-vs-Extreme_Weight |
9.97740001729142E-09 |
| Normal-vs-Obese |
1.84080000131814E-08 |
| Normal-vs-Extreme_Obese |
4.044700E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.446800E-01 |
| Normal_Weight-vs-Obese |
6.167600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.633800E-01 |
| Extreme_Weight-vs-Obese |
6.669000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.704600E-01 |
| Obese-vs-Extreme_Obese |
3.280800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.44980000227335E-08 |
| Normal-vs-Age(41-60Yrs) |
1.09269999715167E-08 |
| Normal-vs-Age(61-80Yrs) |
2.6597000046813E-08 |
| Normal-vs-Age(81-100Yrs) |
1.751999999966E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.216400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.477200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.763800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.366000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.592130E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.014600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.45960004877588E-09 |
| Normal-VS-Type2 PRCC |
4.72850000043934E-07 |
| Normal-VS-KIRP CIMP |
1.75079950537338E-10 |
| Normal-VS-Unclassified PRCC |
8.59759996529874E-09 |
| Type1 PRCC-VS-Type2 PRCC |
2.359100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.204599999864E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
8.006600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.11249939552749E-11 |
| Type2 PRCC-VS-Unclassified PRCC |
1.676270E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.560000E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.63600000108377E-08 |
| Normal-vs-N1 |
5.3540000211072E-09 |
| Normal-vs-N2 |
6.118300E-03 |
| N0-vs-N1 |
1.891190E-01 |
| N0-vs-N2 |
3.321600E-01 |
| N1-vs-N2 |
4.616600E-01 |
|
|
